3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
12
Breast Neoplasms
11
Prostatic Neoplasms
10
Glioblastoma
10
Oropharyngeal Neoplasms
7
Rectal Neoplasms
6
Neoplasms
6
Lung Neoplasms
6
Astrocytoma
6
Squamous Cell Carcinoma of Head and Neck
5
Urinary Bladder Neoplasms
4
Burkitt Lymphoma
4
Adenocarcinoma of Lung
4
Pancreatic Neoplasms
3
Nasopharyngeal Carcinoma
3
Mouth Neoplasms
3
Lymphoma, Follicular
3
Hodgkin Disease
3
Gliosarcoma
3
Glioma
3
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Carcinoma
3
Triple Negative Breast Neoplasms
2
Sarcoma
2
Rhabdomyosarcoma
2
Neoplasm, Residual
2
Mesothelioma, Malignant
2
Meningeal Carcinomatosis
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Fulvestrant
2
tivozanib
1
ribociclib
1
palbociclib
1
niraparib
1
lorlatinib
1
exemestane
1
encorafenib
1
cemiplimab
1
binimetinib
1
abemaciclib
1
Tamoxifen
1
STX-478
1
Metformin
1
Letrozole
1
Imlunestrant
1
Cetuximab
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
Radiotherapy
×
30 days
×
Clear all
No trials found.